Stock Scorecard
Stock Summary for Masimo Corp (MASI) - $135.24 as of 4/26/2024 3:28:26 PM EST
Total Score
5 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for MASI
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for MASI
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for MASI
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for MASI
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for MASI
Financial Details for MASI
Company Overview |
|
---|---|
Ticker | MASI |
Company Name | Masimo Corp |
Country | USA |
Description | Masimo Corporation develops, manufactures and markets non-invasive monitoring technologies and hospital automation solutions globally. The company is headquartered in Irvine, California. |
Sector Name | LIFE SCIENCES |
Industry Name | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/7/2024 |
Stock Price History |
|
Last Day Price | 135.24 |
Last Day Price Updated | 4/26/2024 3:28:26 PM EST |
Last Day Volume | 0 |
Average Daily Volume | 472,103 |
52-Week High | 190.82 |
52-Week Low | 75.22 |
Last Price to 52 Week Low | 79.79% |
Valuation Measures |
|
Trailing PE | 90.01 |
Industry PE | 46.98 |
Sector PE | 56.64 |
5-Year Average PE | 43.39 |
Free Cash Flow Ratio | 43.91 |
Industry Free Cash Flow Ratio | 17.79 |
Sector Free Cash Flow Ratio | 30.65 |
Current Ratio Most Recent Quarter | 2.18 |
Total Cash Per Share | 3.08 |
Book Value Per Share Most Recent Quarter | 25.85 |
Price to Book Ratio | 5.35 |
Industry Price to Book Ratio | 3.23 |
Sector Price to Book Ratio | 22.15 |
Price to Sales Ratio Twelve Trailing Months | 3.56 |
Industry Price to Sales Ratio Twelve Trailing Months | 2.52 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.17 |
Share Statistics |
|
Total Shares Outstanding | 52,913,000 |
Market Capitalization | 7,155,954,120 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | 11/23/2012 |
Last Dividend Amount | 0.75 |
Current Dividend Amount | 1.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | -63.64% |
3-Year Dividend Growth Rate Percentage | -63.64% |
5-Year Dividend Growth Rate Percentage | -63.64% |
All-Time Dividend Growth Rate Percentage | -63.64% |
Dividend Payout Ratio | 0.00% |
Income Statement |
|
Quarterly Earnings Growth YOY | -15.90% |
Annual Earnings Growth | -43.21% |
Reported EPS 12 Trailing Months | 1.51 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | 3.18 |
Net Income Twelve Trailing Months | 81,500,000 |
Net Income Past Year | 81,500,000 |
Net Income Prior Year | 143,500,000 |
Quarterly Revenue Growth YOY | -11.00% |
5-Year Revenue Growth | 19.07% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 163,000,000 |
Total Cash Past Year | 163,000,000 |
Total Cash Prior Year | 202,900,000 |
Net Cash Position Most Recent Quarter | -743,000,000 |
Net Cash Position Past Year | -743,000,000 |
Long Term Debt Past Year | 906,000,000 |
Long Term Debt Prior Year | 956,700,000 |
Total Debt Most Recent Quarter | 906,000,000 |
Equity to Debt Ratio Past Year | 0.60 |
Equity to Debt Ratio Most Recent Quarter | 0.60 |
Total Stockholder Equity Past Year | 1,364,800,000 |
Total Stockholder Equity Prior Year | 1,338,900,000 |
Total Stockholder Equity Most Recent Quarter | 1,364,800,000 |
Options |
|
Put/Call Ratio | 0.59 |
Has Options | Options Chain |
Liquidity Rating | None |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.28 |
MACD Signal | 0.83 |
20-Day Bollinger Lower Band | 110.42 |
20-Day Bollinger Middle Band | 129.57 |
20-Day Bollinger Upper Band | 148.72 |
Beta | 0.98 |
RSI | 45.32 |
50-Day SMA | 123.15 |
200-Day SMA | 186.62 |
System |
|
Modified | 4/27/2024 5:24:41 AM EST |